Author

Marla C. Dubinsky 1

1 Mount Sinai Hosp,NY,United States

BURDEN OF DISEASE IN PAEDIATRIC PATIENTS WITH MODERATE VERSUS SEVERE CROHN’S DISEASE IN THE IMAGINE 1 TRIAL

Frank Ruemmele, Jeffrey S Hyams, Joel Rosh, Marla C. Dubinsky, James Markowitz, Anne Griffiths, Dan Turner, Samantha Eichner, Andreas Lazar, Anne M. Robinson, Bidan Huang, Roopal B Thakkar

Item-level improvements in inflammatory bowel disease questionnaire scores in patients with ulcerative colitis treated with tofacitinib induction therapy

Marla C. Dubinsky, Marco DiBonaventura, Haiyun Fan, Andrew G. Bushmakin, Joseph C. Cappelleri, Eric Maller, Andrew J. Thorpe, Leonardo Salese, Julian Panés

PREGNANCY OUTCOMES IN THE TOFACITINIB ULCERATIVE COLITIS OCTAVE STUDIES

Uma Mahadevan, Daniel C. Baumgart, Marla C. Dubinsky, Nervin Lawendy, Gary S. Friedman, Gauree G. Konijeti, Hans Peter Gröchenig, Thomas V Jones, Amy Marren, Andrew J. Thorpe, Chudy I. Nduaka, Chinyu Su

Faecal calprotectin levels, C-reactive protein levels and partial Mayo score as early predictors of clinical and endoscopic outcomes in adult patients with moderately to severely active ulcerative colitis treated with tofacitinib in a Phase 2 study

Marla C. Dubinsky, David P. Hudesman, nicole kulisek, Leonardo Salese, Jerome Paulissen, Chinyu Su, Fernando Jose Magro Dias

TIME TO LOSS OF EFFICACY FOLLOWING TOFACITINIB INTERRUPTION IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM OCTAVE SUSTAIN

Marla C. Dubinsky, Kofi Clarke, Jochen G. Klaus, Yoram Bouhnik, Arif Soonasra, Andrew J. Thorpe, Haiying Zhang, Gary S. Friedman, Deborah A. Woodworth, Nervin Lawendy, Chinyu Su

Item 1 - 5 / 5
1